ARTAX BIOPHARMA
Artax Biopharma is a development-stage biopharmaceutical company that is dedicated to the development of new therapies for autoimmune and inflammatory diseases. Its technology provides the compounds with the potential to become first-in-class immunomodulators for the treatment of a wide range of autoimmune and inflammatory diseases. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.
ARTAX BIOPHARMA
Social Links:
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
2013-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.artaxbiopharma.com
Total Employee:
1+
Status:
Active
Contact:
617-401-2168
Total Funding:
67.81 M USD
Technology used in webpage:
Google Universal Analytics U.S. Server Location CloudFront
Similar Organizations
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
Ocera Therapeutics
Ocera Therapeutics is a biopharmaceutical company developing novel therapeutics for patients with acute and chronic liver diseases.
Q32 Bio
Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Tarsier Pharma
Tarsier Pharma is a late clinical-stage company that develops treatment for autoimmune and inflammatory ocular diseases.
Viva In Vitro
International biomedical leaders in inflammasome R&D
White Sands Pharma
White Sands Pharma is a Pharmaceuticals Company it a developer of novel treatments for Irritable Bowel Syndrome.
Current Advisors List
Current Employees Featured
Founder
Investors List
Sound Bioventures
Sound Bioventures investment in Venture Round - Artax Biopharma
Belinda Termeer
Belinda Termeer investment in Venture Round - Artax Biopharma
Columbus Venture Partners
Columbus Venture Partners investment in Venture Round - Artax Biopharma
Eli Lilly
Eli Lilly investment in Venture Round - Artax Biopharma
Advent Life Sciences
Advent Life Sciences investment in Venture Round - Artax Biopharma
Columbus Venture Partners
Columbus Venture Partners investment in Series B - Artax Biopharma
Realiza Business Angels
Realiza Business Angels investment in Venture Round - Artax Biopharma
Advent Life Sciences
Advent Life Sciences investment in Series B - Artax Biopharma
Lysosomal Therapeutics
Lysosomal Therapeutics investment in Series B - Artax Biopharma
Realiza Business Angels
Realiza Business Angels investment in Series A - Artax Biopharma
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-29 | Artax Biopharma Appoints D. Scott Batty, Jr., M.D. as Chief Medical Officer |
| 2020-05-13 | Artax Biopharma Names Joseph Lobacki as New Chief Executive Officer |
Official Site Inspections
http://www.artaxbiopharma.com
- Host name: artaxbiopharma.tempurl.host
- IP address: 64.176.201.241
- Location: Andover United States
- Latitude: 42.6508
- Longitude: -71.1607
- Metro Code: 506
- Timezone: America/New_York
- Postal: 01810
More informations about "Artax Biopharma"
Artax Biopharma - Immunomodulation without immunosuppression
Oct 1, 2024 Targeted modulation of the T cell receptor (TCR) activation forms the core of everything we do at Artax Biopharma. We develop candidates that prevent Nck recruitment …See details»
Artax Biopharma - Crunchbase Company Profile
Artax Biopharma is a development-stage biopharmaceutical company that is dedicated to the development of new therapies for autoimmune and …See details»
About Artax - Artax Biopharma
About Artax. Advancing novel treatments for autoimmune diseases. We brought together deeply experienced leaders in the field of immunomodulation to realize the full potential of our first-in …See details»
Artax Biopharma Company Profile | Management and Employees …
Www.artaxbiopharma.com Artax Biopharma Profile and History Artax Biopharma is a clinical-stage biotechnology company transforming T Cell-mediated disease treatment by developing …See details»
Artax Biopharma, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Artax Biopharma, Inc. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
Artax Biopharma Inc - LinkedIn
Artax Biopharma Inc | 1,896 followers on LinkedIn. Developing oral first-in-class Nck blockers for the treatment of T cell mediated autoimmune diseases | Artax Biopharma is a development …See details»
Artax Biopharma - Overview, News & Similar companies - ZoomInfo
Jan 3, 2024 Who is Artax Biopharma. Artax Biopharma is a clinical-stage biotechnology company transforming T Cell-mediated disease treatment by developing innovative small …See details»
Artax Biopharma, Inc. - Drug pipelines, Patents, Clinical trials
For Phase 2a study inquiries, please contact: [email protected]. Phase 2 Immunotherapy. 04 Jan 2024 ... The statistics for drugs in the Pipeline is the current …See details»
Artax Biopharma Appoints Andre Hoekema, Ph.D., to Company’s …
Company Welcomes Dr. Hoekema, a Biotech Veteran with a Track Record of Successful Industry Collaborations. Cambridge, MA, March 7, 2023 – Artax Biopharma, Inc., a clinical stage …See details»
Artax Biopharma Company Profile - Office Locations, Competitors …
Artax Biopharma has 5 employees at their 1 location and $28.01 m in total funding,. See insights on Artax Biopharma including office locations, competitors, revenue, financials, executives, …See details»
Artax Biopharma Inc Information - RocketReach
Artaxbiopharma.com; 4 413427XXXX; 413596XXXX; 772388XXXX; 850980XXXX; View Similar People. Related Companies Converge Consulting, LLC. 42 $769k Amylyx Pharmaceuticals. …See details»
Artax Biopharma | VentureRadar
Website: http://www.artaxbiopharma.com. Develops drugs for autoimmune diseases, offering immune system modulation without immunosuppression. VentureRadar Research ...See details»
Artax Biopharma - PitchBook
Artax Biopharma General Information Description. Developer of small molecules drugs intended to treat autoimmune and inflammatory diseases. The company's drugs eliminate harmful …See details»
Media - Artax Biopharma
Media Artax Biopharma is on a mission to develop new drug candidates which reset the body's autoimmune system to give normal, healthy responses again in patients with T cell mediated …See details»
Artax Biopharma Announces Positive Phase 1 Results for AX-158, …
Phase 1 Findings Demonstrated that Investigational Agent AX-158 Was Well Tolerated at All Doses, with a Profile that Strongly Supports Further Clinical Development EffortsSee details»
Artax Announces Executive Team Changes, Expansion as ... - Artax …
Jan 4, 2024 Discover the latest executive changes at Artax Biopharma as Dr. Rob Armstrong becomes CEO. Anticipate Phase 2a trial results for AX-158 in psoriasis by late 2024.See details»
Artax Biopharma, Inc. (Artax Biopharma, Inc.) - 药物管线_专利_临床 …
We believe the immunomodulation mechanism offered by our investigational agents holds broad potential to revolutionize how these T Cell-driven autoimmune diseases are addressed, while …See details»
Our Clinical Trials - Artax Biopharma
Our Clinical Trials We look forward to seeing what our first-in-class candidate drugs can do for patients. Please join our research mission to improve treatments for autoimmune disease …See details»
Artax Biopharma to present first-in-class Nck modulator …
Oct 1, 2024 For future clinical study inquiries: [email protected]. More news and publications from Artax. See all resources. Scientific Publications ; Nov 20, 2024 . First-in …See details»
Our Pipeline and Progress - Artax Biopharma
Feb 13, 2024 Our Pipeline and Progress. Developing first-in-class Nck modulators for autoimmune disease. Our first-in-class, novel mechanism holds broad potential to treat T cell …See details»